KILL Ambry Genetics Announces Settlement in BRCA1/2 Gene Patent Infringement Case
January 26 2015 - 10:35PM
Business Wire
Ambry Genetics requests that their press release NewsItemId:
20150126006608 entitled “Ambry Genetics Announces Settlement in
BRCA1/2 Gene Patent Infringement Case” be killed.
Please disregard this release, it was issued prematurely by
Ambry Genetics.
A replacement release will be issued at a later date.
Ambry GeneticsHumberto HuertaDirector of
Marketinghhuerta@ambrygen.com949-900-5516